학술논문

Effects of a Water, Sanitation, and Hygiene Mobile Health Program on Diarrhea and Child Growth in Bangladesh: A Cluster-randomized Controlled Trial of the Cholera Hospital-based Intervention for 7 Days (CHoBI7) Mobile Health Program.
Document Type
Article
Source
Clinical Infectious Diseases. 11/1/2021, Vol. 73 Issue 9, pe2560-e2568. 9p.
Subject
*DIARRHEA prevention
*PATIENT aftercare
*CELL phones
*FLUID therapy
*DIARRHEA
*CONFIDENCE intervals
*CHILD development
*HOME care services
*FAMILIES
*WATER supply
*TREATMENT effectiveness
*RANDOMIZED controlled trials
*COMMUNICATION
*HAND washing
*STATISTICAL sampling
*TELEMEDICINE
*GROWTH disorders
Language
ISSN
1058-4838
Abstract
Background The Cholera Hospital-Based Intervention for 7 Days (CHoBI7) mobile health (mHealth) program was a cluster-randomized controlled trial of diarrhea patient households conducted in Dhaka, Bangladesh. Methods Patients were block-randomized to 3 arms: standard message on oral rehydration solution use; health facility delivery of CHoBI7 plus mHealth (no home visits); and health facility delivery of CHoBI7 plus 2 home visits and mHealth. The primary outcome was reported diarrhea in the past 2 weeks collected monthly for 12 months. The secondary outcomes were stunting, underweight, and wasting at a 12-month follow-up. Analysis was intention-to-treat. Results Between 4 December 2016 and 26 April 2018, 2626 participants in 769 households were randomly allocated to 3 arms: 849 participants to the standard message arm, 886 to mHealth with no home visits arm, and 891 to the mHealth with 2 home visits. Children <5 years had significantly lower 12-month diarrhea prevalence in both the mHealth with 2 home visits arm (prevalence ratio [PR]: 0.73 [95% confidence interval {CI},.61–.87]) and the mHealth with no home visits arm (PR: 0.82 [95% CI,.69–.97]). Children <2 years were significantly less likely to be stunted in both the mHealth with 2 home visits arm (33% vs 45%; odds ratio [OR]: 0.55 [95% CI,.31–.97]) and the mHealth with no home visits arm (32% vs 45%; OR: 0.54 [95% CI,.31–.96]) compared with children in the standard message arm. Conclusions The CHoBI7 mHealth program lowered pediatric diarrhea and stunting among diarrhea patient households. Clinical Trials Registration NCT04008134. [ABSTRACT FROM AUTHOR]